This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.
Tuberculosis (TB), especially drug-resistant TB, is a public health challenge in both civilian and penitentiary sectors worldwide. The Global End TB Strategy envisages specific measures to be taken by WHO Member States globally to tackle the problem and address the challenge. The WHO Regional Office for Europe has developed the Tuberculosis Action Plan for 2016–2020 to achieve the milestones and objectives set by the Global End TB Strategy. This first compendium of best practices in TB control in prisons is an essential document for the implementation of the Strategy, providing examples of treatment and care following the recommendations proposed for WHO and its partners.
The Good practices in the prevention and care of tuberculosis and drug-resistant tuberculosis in the correctional facilities compendium can be accessed here.
- Addressing the noncommunicable disease burden in prisons in the WHO European Region
- Hepatitis C virus reinfection following direct acting antiviral treatment in the prison setting: the SToP-C study
- Implementation of novel and conventional outbreak control measures in managing COVID-19 outbreaks in a large UK prison